ARCHIVES

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Viewed As NIH’s ‘Administrative Reserve,” Broder Tells Directors

July 12, 1991

In Brief: NIH Call For Review Group Nominations Brings 8,000 Names For 400 Vacancies

August 17, 1979

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

NCI Programs: Institute Seeks White Papers On Technology

September 11, 1998

NCCN Updates Breast Cancer Guidelines for Patients

October 31, 2003

ASCO Objects To Proposed Graduate Medical Education Bill

September 20, 1985